Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
01 2BUPROPION HYDROCHLORIDE
02 4ISOSORBIDE MONONITRATE
03 1LEVETIRACETAM
04 2METFORMIN HYDROCHLORIDE
05 1OXYBUTYNIN CHLORIDE
06 1REQUIP XL
07 2ROPINIROLE HYDROCHLORIDE
08 1UROXATRAL
01 121287
02 122008
03 175155
04 179226
05 190014
06 190598
07 191395
08 191430
09 1200270
10 1200495
11 1202332
12 1202774
13 1202775
14 1202786
01 14No
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Drug : ISOSORBIDE MONONITRATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 90598
Country : US
Patented : No
Drug : ROPINIROLE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 202786
Country : US
Patented : No
Drug : ROPINIROLE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 91395
Country : US
Patented : No
Drug : ISOSORBIDE MONONITRATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 75155
Country : US
Patented : No
Drug : REQUIP XL
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 22008
Country : US
Patented : No
Drug : BUPROPION HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 202775
Country : US
Patented : No
Drug : BUPROPION HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 202774
Country : US
Patented : No
Drug : LEVETIRACETAM
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 91430
Country : US
Patented : No
Drug : METFORMIN HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 79226
Country : US
Patented : No
Drug : OXYBUTYNIN CHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 202332
Country : US
Patented : No
